ATTWILL Medical Solutions
Attwill Medical Solutions develops and manufactures pharmaceutical ingredients, medical devices, and biologics in Wisconsin, aiming to improve patient care through innovative, competitive, and clinically effective solutions. The company offers contract manufacturing, medical device development, and production, with a focus on lyophilization and infection control devices, supporting healthcare innovation from startup to global scale.
Industries
Nr. of Employees
small (1-50)
ATTWILL Medical Solutions
Lodi, Wisconsin, United States, North America
Patents
Products
HALOGuard Protective Disc with chlorhexidine gluconate
Sterile, single-use hydrophilic absorptive foam disc with a central hole and radial slit, infused with chlorhexidine gluconate for protection of vascular insertion sites and to inhibit microbial growth on dressings.
FILTERGuard disposable IV filter with chlorhexidine gluconate
Sterile single-use in-line IV filter infused with chlorhexidine gluconate designed to trap and kill microbial contaminants from catheter lock solutions prior to entry into the catheter.
HALOGuard Protective Disc with chlorhexidine gluconate
Sterile, single-use hydrophilic absorptive foam disc with a central hole and radial slit, infused with chlorhexidine gluconate for protection of vascular insertion sites and to inhibit microbial growth on dressings.
FILTERGuard disposable IV filter with chlorhexidine gluconate
Sterile single-use in-line IV filter infused with chlorhexidine gluconate designed to trap and kill microbial contaminants from catheter lock solutions prior to entry into the catheter.
Services
End-to-end manufacturing services from formulation through finishing, including lyophilization, sterile device production, packaging and distribution.
Development and optimization of freeze-drying cycles to maximize yield and performance across development stages and scales.
In-house design, prototyping, biocompatibility testing and sterile manufacturing for single-use vascular-access and site-protection devices.
Quality assurance, validation testing, regulatory filing support (e.g., 510(k)) and QA/QC systems to meet FDA and ISO requirements.
Rapid conversion of manufacturing lines to produce materials needed during health emergencies (e.g., hand sanitizer, test kits, vaccine manufacturing capacity support).
End-to-end manufacturing services from formulation through finishing, including lyophilization, sterile device production, packaging and distribution.
Development and optimization of freeze-drying cycles to maximize yield and performance across development stages and scales.
In-house design, prototyping, biocompatibility testing and sterile manufacturing for single-use vascular-access and site-protection devices.
Quality assurance, validation testing, regulatory filing support (e.g., 510(k)) and QA/QC systems to meet FDA and ISO requirements.
Rapid conversion of manufacturing lines to produce materials needed during health emergencies (e.g., hand sanitizer, test kits, vaccine manufacturing capacity support).
Expertise Areas
- Lyophilization and freeze-drying
- Contract development and manufacturing (CDMO)
- Sterile manufacturing and cleanroom operations
- Medical device design for vascular-access and site protection
Key Technologies
- Lyophilization (freeze-drying)
- cGMP manufacturing
- ISO 13485 quality systems
- ISO 7 cleanroom processing
News & Updates
Attwill was proud to host former WI governor and current president of the UW System Tommy Thomson for a roundtable discussion to improve ties between the University and UW system.
Attwill was proud to host U.S. Senator Tammy Baldwin (D-WI) for a roundtable discussion regarding the manufacturing life science components in the United States.
Attwill Medical Solutions™ was proud to host U.S. Representative Glenn Grothman for a roundtable discussion regarding the company, as well as a comprehensive facility tour.
Attwill Medical Solutions™ is pleased to disclose that its HaloGUARD™ product received FDA 510 (k) clearance in September 2020.
Vaxart, Inc. has announced it will be working with Attwill Medical Solutions™ to manufacture its revolutionary oral vaccine for COVID-19.
Attwill Medical Solutions is partnering with a nearby distillery to produce and sell hand sanitizer to hospitals and essential workers.
Attwill was proud to host former WI governor and current president of the UW System Tommy Thomson for a roundtable discussion to improve ties between the University and UW system.
Attwill was proud to host U.S. Senator Tammy Baldwin (D-WI) for a roundtable discussion regarding the manufacturing life science components in the United States.
Attwill Medical Solutions™ was proud to host U.S. Representative Glenn Grothman for a roundtable discussion regarding the company, as well as a comprehensive facility tour.
Attwill Medical Solutions™ is pleased to disclose that its HaloGUARD™ product received FDA 510 (k) clearance in September 2020.
Vaxart, Inc. has announced it will be working with Attwill Medical Solutions™ to manufacture its revolutionary oral vaccine for COVID-19.
Attwill Medical Solutions is partnering with a nearby distillery to produce and sell hand sanitizer to hospitals and essential workers.